The Claim
Intranasal administration of human induced pluripotent stem cell-derived neural stem cell extracellular vesicles reduces the activation of the NLRP3 inflammasome and cGAS-STING signaling pathways in the aged mouse hippocampus, leading to decreased levels of NLRP3, ASC, cleaved caspase-1, p-STING, and IFN-α.
What the research says
Supports is higher
Support is ahead, but a single strong opposing study can change this.
These are independent scores, not a percentage. Higher-grade studies count more, so a single strong opposing study can outweigh several weaker ones.
Intranasal delivery of extracellular vesicles from stem cells reduces the activity of specific inflammatory pathways and lowers levels of key inflammatory proteins in the hippocampus of aged mice.
See the scientific wording
Intranasal hiPSC-NSC-EVs significantly reduce the activation of the NLRP3 inflammasome and cGAS-STING signaling pathways in the aged mouse hippocampus, decreasing levels of key inflammatory proteins including NLRP3, ASC, cleaved caspase-1, p-STING, and IFN-α, which are central drivers of neuroinflammaging.
Tiny bubbles from stem cells, delivered through the nose, enter brain immune cells and release specific molecules that block two key inflammation systems. One molecule stops a protein called NLRP3 from forming a harmful complex, and another molecule stops a protein called STING from turning on a signal that produces inflammatory chemicals. This reduces the release of inflammatory substances that damage brain cells in aging.
What the research says
1 studyScientists gave aging mice a nose spray made from stem cell tiny bubbles, and it quieted down two major inflammation systems in their brains, reducing harmful proteins that cause brain aging.
Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting studies
Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.